相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Additive Protection against Congenital Cytomegalovirus Conferred by Combined Glycoprotein B/pp65 Vaccination Using a Lymphocytic Choriomeningitis Virus Vector
Mark R. Schleiss et al.
CLINICAL AND VACCINE IMMUNOLOGY (2017)
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Anna Bootz et al.
PLOS PATHOGENS (2017)
Complement enhances in vitro neutralizing potency of antibodies to human cytomegalovirus glycoprotein B (gB) and immune sera induced by gB/MF59 vaccination
Fengsheng Li et al.
NPJ VACCINES (2017)
Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial
David I. Bernstein et al.
VACCINE (2016)
The March towards a Vaccine for Congenital CMV: Rationale and Models
Kristy M. Bialas et al.
PLOS PATHOGENS (2016)
Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses
Matthew Zirui Tay et al.
PLOS PATHOGENS (2016)
Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology
Amy W. Chung et al.
CELL (2015)
The history of vaccination against cytomegalovirus
Stanley Plotkin
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2015)
Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies
Wilton B. Williams et al.
SCIENCE (2015)
Structure of HCMV glycoprotein B in the postfusion conformation bound to a neutralizing human antibody
Sumana Chandramouli et al.
NATURE COMMUNICATIONS (2015)
Correction: Crystal Structure of the Human Cytomegalovirus Glycoprotein B
Heidi G. Burke et al.
PLoS Pathogens (2015)
The immunology of human cytomegalovirus latency: could latent infection be cleared by novel immunotherapeutic strategies?
Mark R. Wills et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2015)
Infant HIV Type 1 gp120 Vaccination Elicits Robust and Durable Anti-V1V2 Immunoglobulin G Responses and Only Rare Envelope-Specific Immunoglobulin A Responses
Genevieve G. Fouda et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Medicare Readmission Penalties in Detroit
Kim A. Williams et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Polyfunctional Fc-Effector Profiles Mediated by IgG Subclass Selection Distinguish RV144 and VAX003 Vaccines
Amy W. Chung et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Vaccine-Induced Env V1-V2 IgG3 Correlates with Lower HIV-1 Infection Risk and Declines Soon After Vaccination
Nicole L. Yates et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
IgG subclasses and allotypes: from structure to effector functions
Gestur Vidarsson et al.
FRONTIERS IN IMMUNOLOGY (2014)
The Silent Global Burden of Congenital Cytomegalovirus
Sheetal Manicklal et al.
CLINICAL MICROBIOLOGY REVIEWS (2013)
Neutralizing antibodies are unable to inhibit direct viral cell-to-cell spread of human cytomegalovirus
Christian L. Jacob et al.
VIROLOGY (2013)
License to kill: Formulation requirements for optimal priming of CD8+ CTL responses with particulate vaccine delivery systems
Camilla Foged et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis
Dionne P. Robinson et al.
HORMONES AND BEHAVIOR (2012)
Glycoprotein B Vaccine Is Capable of Boosting Both Antibody and CD4 T-Cell Responses to Cytomegalovirus in Chronically Infected Women
Steffanie Sabbaj et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial
Paul D. Griffiths et al.
LANCET (2011)
B Cell Repertoire Analysis Identifies New Antigenic Domains on Glycoprotein B of Human Cytomegalovirus which Are Target of Neutralizing Antibodies
Sonja Poetzsch et al.
PLOS PATHOGENS (2011)
Isolation of Human Monoclonal Antibodies That Potently Neutralize Human Cytomegalovirus Infection by Targeting Different Epitopes on the gH/gL/UL128-131A Complex
Annalisa Macagno et al.
JOURNAL OF VIROLOGY (2010)
Vaccine Prevention of Maternal Cytomegalovirus Infection
Robert F. Pass et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels
Grazia Galli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Human NK cells can control CMV infection in the absence of T cells
Taco W. Kuijpers et al.
BLOOD (2008)
Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection
Xiaohong Cui et al.
VACCINE (2008)
Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection
Aileen Kenneson et al.
REVIEWS IN MEDICAL VIROLOGY (2007)
Immunogenicity of a recombinant human cytomegalovirus gB vaccine in seronegative toddlers
DK Mitchell et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2002)
分享论文
